StepStone Group’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-522,987
Closed -$18.8M 26
2022
Q4
$18.8M Hold
522,987
2.45% 7
2022
Q3
$7.87M Hold
522,987
1.12% 14
2022
Q2
$7M Hold
522,987
0.75% 17
2022
Q1
$10.1M Hold
522,987
0.75% 13
2021
Q4
$12.4M Hold
522,987
0.71% 14
2021
Q3
$8.37M Buy
+522,987
New +$11.2M 0.54% 14

StepStone Group's IMGO Position: Q1 2023 in Review

StepStone Group sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 522,987 shares — an estimated $18.8M sold.

StepStone Group first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $18.8M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • StepStone Group reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
  • StepStone Group sold 522,987 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $18.8M.
  • StepStone Group first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
  • StepStone Group's Imago BioSciences, Inc. Common stock position peaked at $18.8M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on StepStone Group's 13F filing for Q1 2023, filed 15 May 2023.